Background
X1 and X2, the joint inventors of inventions concerning quantum-dot technology, sought declarations that each retained a one-half share of the rights to obtain patents for three groups of claimed inventions. The patent applications had been filed in the name of zSustainergy Co., Ltd., formerly QD Japan Co., Ltd., a company established by X2 to research, develop, and commercialize quantum-dot technology.
The Tokyo District Court rejected the claims, finding that the inventors and the company had agreed, no later than the filing of the applications, to transfer the inventors’ shares in the rights to obtain the patents to the company. On appeal, the inventors additionally argued that the transfer was conditioned on the company maintaining a research-and-development environment and entering into a definitive agreement to pay X1 five percent of sales from quantum-dot solar cells. They asserted that the company had abandoned the business and purported to rescind the transfer without notice under Article 542(1)(v) of the Civil Code.
The Court’s Holding
The Intellectual Property High Court dismissed both appeals and affirmed the judgment for zSustainergy. Adopting the district court’s reasoning with modifications, it held that the inventors had transferred their shares in the rights to obtain the patents to the company by the time the applications were filed. Although the inventors reviewed application materials and requested changes to the named inventors and to the specifications and claims, they did not object to QD Japan being identified as the applicant.
The court found insufficient evidence of the alleged conditions or promised five-percent sales agreement. No definitive contract was executed, even though X2 was initially the company’s sole director and was later advised to formalize an agreement protecting the inventors’ rights. The proposed contract contained materially different compensation terms, including 0.5 percent of product sales and five percent of licensing revenue. The alleged obligation to maintain a research environment was also undefined. Even if the assignment could be understood as carrying some obligation to pursue commercialization, the company had filed the applications, requested examination, sought investment, remained in existence after a change of control, and planned to continue exploiting its technology. The court therefore could not find that it had entirely abandoned the business or failed to perform such an obligation, so the asserted rescission did not restore the inventors’ rights.
Key Takeaways
- Inventors may be found to have assigned rights to obtain patents through their agreement and conduct even without a signed definitive assignment contract.
- Reviewing patent applications without objecting to the company being named as applicant supported the finding that the rights had been transferred.
- An assignment cannot readily be rescinded for breach of vaguely defined commercialization or research obligations, particularly where the assignee continues prosecution, fundraising, and business-planning efforts.
Why It Matters
The decision highlights the importance of documenting patent assignments, compensation arrangements, and commercialization obligations when founders contribute inventions to a new company. Draft agreements and expectations about future royalties may not establish binding conditions if the parties never finalize the terms.
For technology ventures dependent on long-term and uncertain research, the judgment also shows that courts will examine whether alleged performance conditions are sufficiently specific and whether the company has genuinely abandoned the contemplated business before permitting rescission of an assignment.